The FTC released a scathing interim report on PBMs. What’s next?

The latest stories trending on MedCity News.

Editor's Pick

Top Story The FTC Released a Scathing Interim Report on PBMs. What's Next? The Federal Trade Commission recently released an interim report that details how the practices of pharmacy benefit managers negatively impact patients and pharmacies. Some experts hope for legislative action based on the report. Sponsored Streamlining Healthcare: How Technology is Removing Friction for Providers Presented by MedCity News & Greenway Health Here's a look at three innovative software solutions that support healthcare transformation and are having a significant impact.  Read More.  Final Chance: Get Your INVEST Digital Health Super Early Bird Tickets NOW The Super Early Bird rate expires TONIGHT at 11:59pm ET. Save $150 – secure your discounted tickets today! Connect with peers, investors, and professionals driving advancements in healthcare technology.  Get the top rate for the can't-miss event of the season, INVEST Digital Health, September 18 at Pegasus Park in Dallas. Save $150, Register NOW

Featured News

Heartburn Drug from Phathom Pharma Expands Its Approval to Cover More GERD Patients Expanded FDA approval of Phathom Pharmaceuticals drug Voquezna now includes patients with non-erosive gastroesophageal reflux disease (GERD). Phathom licensed its flagship product from Takeda Pharmaceutical. Specialty Pharmacy: A Sound Strategy to Weather Hospital Financial Storms, Enhance Patient Care In addition to increasing medication access for underserved populations, an in-house specialty pharmacy improves patient care and provides opportunities for efficiency and enhancement across hospital operations. Supplemental Benefits are Worth Fighting for to Support Senior Health The new CMS guidelines represent a transformative moment for Medicare Advantage — here are three ways to be good stewards of taxpayer dollars and create a healthier future for seniors What the Medicare Quality Rating Change Means for Healthcare Companies — and Patient Health SMS is reevaluating its Star Ratings. Not only do health plans stand to benefit from the new calculations — all healthcare companies and millions of patients will reap the rewards.

Resources

Debunked | No-Fluff Healthcare News Show | Presented by MedCity News | Episode 6 In this episode, we talk about hospital consolidation and recent Supreme Court decisions affecting healthcare. Companies and organizations mentioned in this episode are Risant Health, Kaiser Permanenete, Cone Health, Geisinger, General Catalyst, Summa Health, FDA, the Supreme Court. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe